We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Signaling its intention to beef up safety monitoring of products destined for America, the U.S. Food and Drug Administration (FDA) says it will open two offices in India by next year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor